Bunge Global SA
BG Consumer Defensive Farm Products
Bunge Global SA’s revenue for fiscal 2025 (year ended December 2025) was $70.3 billion, up 32.4% from fiscal 2024. In the quarter to June 2026, revenue grew 88.3%, EPS grew 33.0%, free cash flow was flat and total debt rose 35.0%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years; insiders bought in the last twelve months.
Follow BG
Bunge Global SA (BG) EPS (diluted)
Bunge Global SA's EPS (diluted) for fiscal 2025 was $4.91, down 38.5% from $7.99 in fiscal 2024. Over the twelve months to 30 June 2026 it was $5.15. Over the past ten years it has ranged from −$9.34 (fiscal 2019) to $14.87 (fiscal 2023); the current reading is higher than 36% of that period. Bunge Global SA ranks 2nd of 21 Farm Products companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2025 | $4.91 | (38.55%) |
| FY2024 | $7.99 | (46.27%) |
| FY2023 | $14.87 | 41.48% |
| FY2022 | $10.51 | (22.95%) |
| FY2021 | $13.64 | 76.91% |
| FY2020 | $7.71 | — |
| FY2019 | −$9.34 | — |
| FY2018 | $1.64 | 84.27% |
| FY2017 | $0.89 | (82.24%) |
| FY2016 | $5.01 | (1.18%) |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Jun 2026 | $3.47 | 891.43% |
| Mar 2026 | $0.35 | (28.57%) |
| Dec 2025 | $0.49 | (41.67%) |
| Sep 2025 | $0.84 | (67.82%) |
| 42 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| IBA Industrias Bachoco, S.A. de C.V. compare | $5.80 |
| BG Bunge Global SA | $5.15 |
| ADM Archer Daniels Midland Company compare | $3.65 |
| TSN Tyson Foods, Inc. compare | $1.62 |
| CALM Cal-Maine Foods, Inc. compare | $1.23 |
| DMC Del Monte Corporation compare | $0.71 |
| DOLE Dole PLC compare | $0.62 |
| AGRO Adecoagro S.A. compare | $0.33 |
| VITL Vital Farms, Inc. compare | −$0.04 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on BG
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement